Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease

Journal of Heart and Lung Transplantation

Volumn 32, Issue 3, 2013, Pages 347-354

  Carlsen, Jørn ^a   Hasseriis Andersen, Kasper ^a   Boesgaard, Søren ^a   Iversen, Martin ^a   Steinbrüchel, Daniel ^b   Bøgelund Andersen, Claus ^b  

^a Copenhagen University ^*  (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

chronic obstructive pulmonary disease; explanted lungs; pulmonary hypertension; transplantation; vascular lesions

Indexed keywords

ADULT; ARTICLE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; LUNG ARTERY; LUNG ARTERY PRESSURE; LUNG CAPACITY; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; TOTAL LUNG CAPACITY;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84873989348     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.11.014     Document Type: Article

References (40)

1. O.A. Minai, A. Chaouat, and S. Adnot Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective Chest 137 6 Suppl 2010 39 51S
2. A. Chaouat, A.S. Bugnet, and N. Kadaoui Severe pulmonary hypertension and chronic obstructive pulmonary disease Am J Respir Crit Care Med 172 2005 189 194
3. N. Galiè, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
4. K.H. Andersen, M. Iversen, and J. Kjaergaard Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease J Heart Lung Transplant 31 2012 373 380
5. G. Simonneau, I.M. Robbins, and M. Beghetti Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 1 Suppl 2009 S43 S54
6. R.M. Tuder, J.C. Marecki, A. Richter, I. Fijalkowska, and S. Flores Pathology of pulmonary hypertension Clin Chest Med 28 2007 23 42 vii
7. E. Weitzenblum, A. Sautegeau, M. Ehrhart, M. Mammosser, and A. Pelletier Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 131 1985 493 498
8. A. Chaouat, R. Naeije, and E. Weitzenblum Pulmonary hypertension in COPD Eur Respir J 32 2008 1371 1385
9. Orens J.B., Estenne M., Arcasoy S., et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. All rights reserved.. J Heart Lung Transplant 2006;25:745-55.
10. M.R. Miller, R. Crapo, and J. Hankinson General considerations for lung function testing Eur Respir J 26 2005 153 161
11. M.R. Miller, J. Hankinson, and V. Brusasco Standardisation of spirometry Eur Respir J 26 2005 319 338
12. J. Wanger, J.L. Clausen, and A. Coates Standardisation of the measurement of lung volumes Eur Respir J 26 2005 511 522
13. American Thoracic Society Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique - 1995 update Am J Respir Crit Care Med 152 1995 2185 2198
14. P.H. Quanjer, G.J. Tammeling, and J.E. Cotes [Lung volumes and forced ventilatory flows. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society] French. Rev Mal Respir 11 Suppl 3 1994 5 40
15. J.E. Cotes, D.J. Chinn, P.H. Quanjer, J. Roca, and J.C. Yernault [Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society]. French Eur Respir J Suppl 11 Suppl 3 1994 41 52
16. D. Heath, and J.E. Edwards The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects Circulation 18 1958 533 547
17. W.D. Travis, T.V. Colby, and M.N. Koss Non-neoplastic disorders of the lower respiratory tract 2002 American Registry of Pathology Washington, DC p. 769
18. D. Jonigk, H. Golpon, and C.L. Bockmeyer Plexiform lesions in pulmonary arterial hypertension. composition, architecture, and microenvironment Am J Pathol 179 2011 167 179
19. K. Matsui, Y. Takano, and Z.X. Yu Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy Pathol Res Pract 198 2002 403 412
20. E. Weitzenblum, and A. Chaouat Severe pulmonary hypertension in COPD: is it a distinct disease? Chest 127 2005 1480 1482
21. J.P. Wrobel, B.R. Thompson, and T.J. Williams Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review J Heart Lung Transplant 31 2012 557 564
22. N.F. Voelkel, J. Gomez-Arroyo, and S. Mizuno COPD/emphysema: the vascular story Pulm Circ 1 2011 320 326
23. J.A. Barberà, and I. Blanco Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management Drugs 69 2009 1153 1171
24. J.L. Wright, T. Petty, and W.M. Thurlbeck Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial Lung 170 1992 109 124
25. X.G. Sun, J.E. Hansen, R.J. Oudiz, and K. Wasserman Exercise pathophysiology in patients with primary pulmonary hypertension Circulation 104 2001 429 435
26. G. Thabut, G. Dauriat, and J.B. Stern Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation Chest 127 2005 1531 1536
27. G.G. Pietra, F. Capron, and S. Stewart Pathologic assessment of vasculopathies in pulmonary hypertension J Am Coll Cardiol 43 12 Suppl S 2004 25S 32S
28. I. Chavoza, J.E. Loyd, and V.S. Zhdanov Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension Am J Path 146 1995 389 397
29. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-8.
30. D. Stolz, H. Rasch, and A. Linka A randomised, controlled trial of bosentan in severe COPD Eur Respir J 32 2008 619 628
31. S. Holverda, H. Rietema, and H.J. Bogaard Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD Pulm Pharmacol Ther 21 2008 558 564
32. I. Blanco, E. Gimeno, and P.A. Munoz Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension Am J Respir Crit Care Med 181 2010 270 278
33. H. Rietema, S. Holverda, and H.J. Bogaard Sildenafil treatment in COPD does not affect stroke volume or exercise capacity Eur Respir J 31 2008 759 764
34. D.J. Lederer, M.N. Bartels, and N.W. Schluger Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial COPD 9 2012 268 275
35. R. Naeije, C. Melot, P. Mols, and R. Hallemans Reduction in pulmonary hypertension by prostaglandin E1 in decompensated chronic obstructive pulmonary disease Am Rev Respir Dis 125 1982 1 5
36. K. Jones, T. Higenbottam, and J. Wallwork Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension Chest 96 1989 784 789
37. M. Humbert, and G. Simonneau Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: not ready for prime time! Am J Respir Crit Care Med 181 2010 202 203
38. M. Oswald-Mammosser, M. Apprill, P. Bachez, M. Ehrhart, and E. Weitzenblum Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type Respiration 58 1991 304 310
39. C.C. Christensen, M.S. Ryg, A. Edvardsen, and O.H. Skjønsberg Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients Eur Respir J 24 2004 580 586
40. R. Kessler, M. Faller, and E. Weitzenblum Natural history of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease Am J Respir Crit Care Med 164 2001 219 224